Drug factory · FDA FEI 3003418999
Patheon Biologics LLC
4766 LaGuardia Drive, Saint Louis, MO, United States
Problems found, fixed voluntarily at FDA's last inspection, Nov 20, 2024.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
7 drug inspections on record since 2010: 1 with no problems, 6 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Lerodalcibep | Makes the active ingredient | LIB Therapeutics, Inc. | 84685-300 |
| Olipudase Alfa | Makes the active ingredient and tests it | Genzyme Corporation | 58468-0050, 58468-0051 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 20, 2024 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Dec 8, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 2, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Aug 2, 2019 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 21, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Apr 3, 2012 | No problems found | Drug Quality Assurance | — |
| Jun 23, 2010 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture.